FBT 134 Pill - blue capsule/oblong, 17mm

Pill with imprint FBT 134 is Blue, Capsule/Oblong and has been identified as Fenofibrate 134 mg. It is supplied by Aurobindo Pharma Limited.

Fenofibrate is used in the treatment of Hypertriglyceridemia; High Cholesterol; Hyperlipoproteinemia Type IIa, Elevated LDL; Hyperlipoproteinemia; Hyperlipoproteinemia Type IV, Elevated VLDL and belongs to the drug class fibric acid derivatives. Risk cannot be ruled out during pregnancy. Fenofibrate 134 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for FBT 134

Imprint: FBT 134
Strength: 134 mg
Color: Blue
Size: 17.00 mm
Shape: Capsule/Oblong
Availability: Prescription only
Drug Class: Fibric acid derivatives
Pregnancy Category: C - Risk cannot be ruled out
CSA Schedule: Not a controlled drug
Labeler / Supplier: Aurobindo Pharma Limited
National Drug Code (NDC): 59651-0202
Inactive Ingredients: silicon dioxide, croscarmellose sodium, D&C Red No. 28, gelatin, magnesium stearate, microcrystalline cellulose, poloxamer 407, povidone k25, sodium lauryl sulfate, titanium dioxide, FD&C Blue No. 1, ferrosoferric oxide, potassium hydroxide, shellac
Note: Inactive ingredients may vary.

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Drug Status

Availability Prescription only Rx

Pregnancy & Lactation Risk data available

CSA Schedule* Not a controlled drug N/A

Approval History Drug history at FDA

User Reviews & Ratings

5.7 / 10